| 产品详情 |
| Edit |   |
|---|
| Product Name | Verdinexor |
|---|
| Description | An inhibitor of XPO1/CRM1 with anticancer and antiviral activities; inhibits the growth of OCI-Ly3, OCI-Ly10, and CLBL1 DLBCL cells (IC50s = 2.1, 41.8, and 8.5 nM, respectively); inhibits XPO1/CRM1-mediated nuclear transport of RSV M protein at >1 µM; reduces RSV A2 replication (IC50 = 0.96 µM) without affecting viability of A549 cells (CC50 = >38 µM); reduces virus shedding, pulmonary TNF-α, IL-6, MCP01, and IFN-γ expression, and leukocyte infiltration into the bronchoalveolar space in a mouse model of influenza A viral infection at 20 mg/kg |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | KPT-335 |
|---|
| Gene, Accession, CAS # | CAS: 1392136-43-4 |
|---|
| Catalog # | 26171-5 |
|---|
| Price | |
|---|
| Order / More Info | Verdinexor from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|